Batch / Best before: See packaging
If a patient develops hemorrhagic cystitis, he or she will be taken off of cyclophosphamide
, Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancer , Molecular Biosystems , 2014Journal Article, 2014, URL O'Grady S, Finn SP, Cuffe S, Richard DJ, O'Byrne KJ, Barr MP., The role of DNA repair pathways in cisplatin resistant lung cancer, Cancer Treatment Reviews , 40, (10), 2014, p1161 - 1170Review Article, 2014, DOI , URL Heavey S, Godwin P, Baird AM, Barr MP, Umezawa K, Cuffe S, Finn S, O'Byrne K, Gately K., Strategic targeting of the PI3K-NFkB axis in cisplatin resistant NSCLC, Cancer Biology & Therapy , 15, (10), 2014, p1367 - 1377Journal Article, 2014, URL Barr MP, MacDonagh L, O'Byrne KJ., Markers of response to platinum-based chemotherapy in lung cancer, Lung Cancer Management , 2, (3), 2013, p1 - 13Review Article, 2013, DOI Gao Y, Baird AM, Barr MP, Gately K, O'Byrne KJ, Gray SG., Epigenetic therapy for cisplatin resistance in non-small cell lung cancer: the way forward?, Lung Cancer Management , 2, (1), 2013, p1 - 4Review Article, 2013, DOI O'Flathery JD, Barr M, Fennell D, Richard D, Reynolds J, O'Leary J, O'Byrne K., The Cancer Stem-Cell Hypothesis: Its Emerging Role in Lung Cancer Biology and its Relevance for Future Therapy, Journal of Thoracic Oncology , 7, (12), 2012, p1880 - 1890Review Article, 2012, DOI , URL Molecular Mechanisms of Cisplatin Resistance in Lung Cancer
Rigorous, well-controlled human clinical trials are the necessary next step to validate these promising preclinical findings
